Download PDF
CC BY-NC-ND 4.0 · Journal of Coloproctology 2023; 43(04): e267-e270
DOI: 10.1055/s-0043-1776979
Original Article

Assessment of Quality-of-Life in Cancer Patients at Tertiary Care Hospital in North India

Bintoo Sharma
1   ISF College of Pharmacy, Moga, Punjab, India
,
Harsh Tyagi 
1   ISF College of Pharmacy, Moga, Punjab, India
,
Ranjeet Kumar
1   ISF College of Pharmacy, Moga, Punjab, India
,
Amit Sharma
1   ISF College of Pharmacy, Moga, Punjab, India
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Introduction Cancer is a disease that emerges as a result of abnormal cell proliferation and their propensity to spread from one bodily region to another. There are over a hundred different types of cancer that impact individuals all over the world. It is difficult to identify in the early stages, but there are certain warning signals that the cells will turn malignant. Quality of life (QOL) is described by the World Health Organisation as “individuals' perception of life, values, objectives, standards, and interests within the cultural framework of the social environment in which they live and in relation to their goals, expectations, standards, and concerns.” QOL assessment in health system is a multidimensional construct that can be measured by evaluating objective levels of health status filtered by the subjective perceptions and expectations of the individual.

Aim and Objective To assess socio-demographic factors and quality of life among cancer patients in tertiary care hospital.

Materials and Methods A hospital-based prospective observational study was conducted at Guru Gobind Singh Medical College and Hospital Faridkot district, Punjab (India). The study was conducted for a period of six months after getting approval from Institutional Ethical Committee (IEC). Generic instrument, SF-36 was used to assess the QOL. The study was analyzed on SPSS version 26.0 software. Descriptive and analytical analysis was used to describe the results.

Results Linear regression was conducted to see the relationship of physical functioning score with age and weight of the patients. The descriptive statistics shows the mean and standard deviation of the variable. The mean of physical functioning score was found to be (M = 27.82, SD = 15.635). The physical functioning score and age, weight of the patients in linear regression shows that the age and weight explain 17.5%

Conclusion Treatment revealed that severe and moderate activities restricted nearly half of the assessed patients, with body pain interfering with employment and routine activities. According to the findings of the current study, QOL deteriorates as the disease progresses. Cancer unquestionably has a detrimental influence on patients' quality of life, which is connected to the illness process itself, the therapy administered, and the length of the disease.

Keywords

quality of life - sociodemographic - neurons - cancer - BMF

Authors Contributions

Mr. Bintoo Sharma is the major contributor to the manuscript writing, and Dr. Ranjeet Kumar given concept of title and review the manuscript, Dr. Amit Sharma, Mr. Harsh Tyagi is the major contributor in editing and drafting the manuscript.


Statement of Ethics

Not Applicable.




Publication History

Received: 23 June 2023

Accepted: 24 October 2023

Article published online:
27 November 2023

© 2023. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutrition & metabolism. 2010; Dec; 7: 1-22
    PubMedGoogle Scholar
  • 2 Knorr DA, Bachanova V, Verneris MR, Miller JS. Clinical utility of natural killer cells in cancer therapy and transplantation. Semin Immunol 2014; 26 (02) 161-172 . Academic Press
    CrossrefPubMedGoogle Scholar
  • 3 Shrishrimal RP, Sharma KS, Sonawane S, Sonawane P, Varpe VV. On barks of Cinnamomomum zeylanicum Nees. International Journal of Research in Pharmacy and Pharmaceutical Sciences 2016; 1 (05) 1-9
    Google Scholar
  • 4 Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246 (4936) 1406-1412
    CrossrefPubMedGoogle Scholar
  • 5 Montazeri A, Gillis CR, McEwen J. Measuring quality of life in oncology: is it worthwhile? II. Experiences from the treatment of cancer. Eur J Cancer Care (Engl) 1996; 5 (03) 168-175
    CrossrefPubMedGoogle Scholar
  • 6 Arnold-Wörner N, Holle R, Rathmann W, Mielck A. The importance of specialist treatment, treatment satisfaction and diabetes education for the compliance of subjects with type 2 diabetes - results from a population-based survey. Exp Clin Endocrinol Diabetes 2008; 116 (02) 123-128
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Gautam Y, Sharma A, Agarwal A, Bhatnagar M, Trehan RR. A cross-sectional study of QOL of diabetic patients at tertiary care hospitals in Delhi. Indian J Community Med 2009; 34 (04) 346-350
    CrossrefPubMedGoogle Scholar